Clinical Trials Logo
  1. Home
  2. Pancreatitis, Acute Necrotizing
  3. NCT00061438

A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died

Pancreatitis, Acute Necrotizing Clinical Trial

Official title:
A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects With Severe Acute Necrotizing Pancreatitis

Clinical Trial Summary

This is a research study in patients having a condition known as necrotizing pancreatitis. This is inflammation of the pancreas (an intestinal organ which assists with digestion) that has resulted in the damage and death of some pancreatic tissue. This damaged pancreatic tissue may develop a bacterial infection, which can cause further -sometimes very serious- health problems.

It may be possible to prevent or delay infection by giving 'prophylactic' antibiotics (that is - to provide protection before any infection starts). However, it is not certain that this antibiotic therapy will be successful.

This study is being carried out to see whether the antibiotic 'Meropenem' (which is also known as MERREM I.V.) provides protection from developing a pancreatic infection. This will be done by comparing the progress of patients who receive meropenem with those who receive a non-active placebo solution (a solution that does not contain any active medication).

Meropenem or placebo would be given in addition to the standard treatment received for pancreatitis.

It is not known if meropenem will help prevent infections associated with necrotizing pancreatitis.

Approximately 240 patients will take part in this study.

Study participation will be carried out for up to 6 weeks, and patients will receive the study treatment up to a maximum of 21 days.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00061438
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 4
Start date February 2003
Completion date December 2004
View Details
See also
  Status Clinical Trial Phase
Completed NCT00061269 - Videoendoscopic Drainage of Infected Pancreatic Collections N/A
Recruiting NCT05530772 - Immediate vs. On-demand Endoscopic Necrosectomy in Infected Walled-off Pancreatic Necrosis N/A
Not yet recruiting NCT00508729 - Effect of Traditional Chinese Medicine on GI Function Recovery and Nutrition Support in SAP Phase 2/Phase 3
Recruiting NCT00506337 - Evaluation of Effect of Integrated Treatment by Traditional Chinese and Western Medicine for Severe Acute Pancreatitis Phase 2/Phase 3
Recruiting NCT05601687 - Endoscopic Step-up Approach vs Aggressive Debridement of Large Pancreatic Walled-off Necrosis N/A
Completed NCT03923686 - Lumen-apposing Metal Stent With or Without Coaxial Plastic Stent for Treatment of Walled-off Pancreatic Necrosis N/A
Completed NCT02473406 - Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis Phase 4
Recruiting NCT05451901 - Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis N/A
Recruiting NCT04443595 - Dual-scopic Pancreatic Necrosectomy (DPN) N/A
Not yet recruiting NCT06134024 - The Role of Double Pigtail Plastic Stents During Endoscopic Transmural Drainage of Pancreatic Fluid Collections. N/A
Not yet recruiting NCT02691598 - Dexmedetomidine Hydrochloride in the Prevention of Organ Failure Following Severe Acute Pancreatitis Phase 4
Completed NCT03643900 - The Efficacy of Pancreatic Duct Stenting With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis N/A
Terminated NCT03245619 - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Investigation of GSK3335065 Intravenous (IV) Infusion in Healthy Adults Phase 1
Recruiting NCT02133014 - The Study of Laparoscopic-assisted Percutaneous Catheter-directed Drainage to Treat Early Severe Acute Pancreatitis N/A